Subcutaneous ketamine infusion in palliative patients for major depressive disorder (SKIPMDD)—Phase II single-arm open-label feasibility study. - Lee, Wei; Sheehan, Caitlin; Chye, Richard; Chang, Sungwon; Bayes, Adam; Loo, Colleen; Draper, Brian; Agar, Meera R.; Currow, David C. (PLoS ONE, 2023)